SCHEMBL23534267

SCHEMBL23534267

CC(C)(C)OC(=O)Nc1ccc(C(C)(C#N)C(=O)OC(C)(C)C)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ DEGS1 O15121 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ GRIN2B Q13224 1/20 0.37
▸ BCL2 P10415 1/20 0.37
▸ F13A1 P00488 1/20 0.36
▸ TGM2 P21980 1/20 0.36
▸ TGM1 P22735 1/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30058570 1.00 NAMPT (0.39) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL31292326 0.86 HDAC1 (0.41) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL23534356 0.82 LMNA (0.37) ALDH1A1KMT2AATRGAAMAPKAPK2
SCHEMBL23535263 0.81 HDAC1 (0.41) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL282866 0.81 DEGS1 (0.51) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL30099126 0.81 ATR (0.39) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL23582524 0.79 HDAC1 (0.41) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL31357577 0.79 HDAC1 (0.41) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL23582651 0.79 GSK3B (0.43) NAMPTHDAC1GSK3BDYRK1ADEGS1
SCHEMBL24738932 0.79 GAA (0.45) NAMPTHDAC1GSK3BDYRK1ADEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441730-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2025-10-14 — — US disclosed
US-20230114091-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-04-13 — — US disclosed
WO-2021126729-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230114091-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 NAMPT 2453/4885HDAC1 387/4885GSK3B 2034/4885
US-12441730-B2 PRMT5 inhibitors PRMT5, PRMT1, PRMT3 NAMPT 2453/4885HDAC1 387/4885GSK3B 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback